Kyung-Hwa Sun
Primary Care · Duluth, GANPI 1699469528
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 132 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 23.0% — the pattern of someone who eats at a lot of different presentations.
Across 132 payments — averaging $19.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$590
- Gilead$322
- Amgen$299
- Bayer$261
- AstraZeneca$193
- Sumitomo Pharma America, Inc.$172
- plus $724 from 18 others
What the payments were for
- Food & beverage$2,561100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 33 | $590 |
| Gilead | 15 | $322 |
| Amgen | 19 | $299 |
| Bayer | 10 | $261 |
| AstraZeneca | 7 | $193 |
| Sumitomo Pharma America, Inc. | 9 | $172 |
| Ardelyx, Inc. | 6 | $149 |
| Esperion Therapeutics, Inc. | 6 | $98 |
| Novo Nordisk | 5 | $87 |
| Alk-abello, Inc | 3 | $54 |
| Lilly USA, LLC | 2 | $35 |
| Aimmune Therapeutics, Inc. | 2 | $33 |
| Astellas Pharma US Inc | 2 | $33 |
| Pfizer | 2 | $31 |
| Actelion Pharmaceuticals US, Inc. | 1 | $28 |
| Merck | 2 | $28 |
| Lundbeck LLC | 1 | $21 |
| Phadia US Inc. | 1 | $20 |
| Almatica Pharma LLC | 1 | $19 |
| Scilex Pharmaceuticals Inc. | 1 | $19 |
| Exact Sciences | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| Boehringer Ingelheim | 1 | $17 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Creon$114
How this compares
$2,561 in reported general payments places this provider in the 80th percentile of 235 primary care providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 19 | $1,294 |
| Atorvastatin Calcium | 34 | $243 |
| Pantoprazole Sodium | 25 | $102 |
| Naproxen | 22 | $93 |
| Levothyroxine Sodium | 11 | $72 |
| Rosuvastatin Calcium | 13 | $48 |
| Amlodipine Besylate | 15 | $45 |
| Losartan Potassium | 14 | $39 |
| Metformin Hcl | 19 | $37 |
| Azithromycin | 12 | $25 |
Paid to pharmacies, not to this prescriber.
Other primary care in Duluth
- Pamela TurkDouglas$15K
- Morgan JonesLawrenceville$14K
- Jessi HaleColumbus$13K
- Meredith CarrAugusta$12K
- Ashtyn ZaryckiSavannah$12K
- Zanetta BryantNewnan$11K
- Hannah CummingsSuwanee$9K
- Michelle LadewigGainesville$7K
- Lucia OcanoviciuCanton$7K
- Sarah NewGrovetown$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.